AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market 2019-2023| Reformulation of Marketed Drugs to Boost Growth| Technavio

May 20, 2019
Technavio has published a new market research report on the global attention deficit hyperactivity disorder (ADHD) drugs market from 2019-2023 (Graphic: Business Wire)

LONDON--(BUSINESS WIRE)--May 20, 2019--

The global attention deficit hyperactivity disorder (ADHD) drugs market is expected to post a CAGR of close to 6% during the period 2019-2023, according to the latest market research report by Technavio.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005364/en/

Technavio has published a new market research report on the global attention deficit hyperactivity disorder (ADHD) drugs market from 2019-2023 (Graphic: Business Wire)

With the growing prevalence of attention deficit hyperactivity disorder across the world, the ADHD market is witnessing an increase in the number of government initiatives to promote the awareness of the disease and to fund drug development in the area mental health therapeutics. For instance, in 2016, the US Department of Health and Human Services (HHS) donated USD 3,454 million to the Substance Abuse and Mental Health Services Administration (SAMHSA) to address the needs of people with mental illnesses. Such rising government support to help people with ADHD will drive market growth during the forecast period.

As per Technavio, the reformulation of marketed drugs will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global attention deficit hyperactivity disorder (ADHD) drugs market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

Global attention deficit hyperactivity disorder (ADHD) drugs market: Reformulation of Marketed Drugs

Earlier, the ADHD market was dominated by immediate-release tablets for oral use. However, the short duration of action of these drugs necessitates multiple dosing, thereby decreasing patient compliance. Thus, to combat this situation, vendors in the market are increasingly focusing on the reformulation of various marketed drugs. The reformulation of marketed drugs provides an opportunity to grab patent term extensions, which can delay the entry of generic versions in the market. The reformulation of drugs also helps in reducing the dosage frequency, thereby increasing patient compliance.

“Apart from the reformulation of marketed drugs, several other factors such as the rising incidence rate of ADHD among children, growing off-label use of ADHD medications among children, and the increase in M&A will have a significant impact on the growth of the ADHD drugs market during the forecast period,” says a senior research analyst at Technavio.

Global attention deficit hyperactivity disorder (ADHD) drugs market: Segmentation analysis

This market research report segments the global attention deficit hyperactivity disorder (ADHD) drugs market by product (stimulants, and non-stimulants) and geographic regions (North America, Europe, Asia, and ROW)

The North American region led the market in 2018, followed by Europe, Asia, and ROW, respectively. The growth of the ADHD medications market in North America can be attributed to the rising prevalence of ADHD among the population in the US and the increased availability of approved medication therapy for the treatment.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190520005364/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Technavio Research

Copyright Business Wire 2019.

PUB: 05/20/2019 09:20 AM/DISC: 05/20/2019 09:20 AM

http://www.businesswire.com/news/home/20190520005364/en

All contents © copyright 2019 The Associated Press.All rights reserved.